Neuroendocrine findings in anxiety disorders.
Anxiety disorders are newly defined syndromes in which inappropriate state anxiety is the sole or primary symptom. Hormonal manifestations of acute stress are usually minimal or absent in these disorders. A number of findings suggest receptor downregulation or enzyme induction of sorts that would be expected to mute or dampen these responses.
Curtis
G C
GC
University of Michigan, School of Medicine, Ann Arbor.
Glitz
D A
DA
D000324:Adrenocorticotropic Hormone / Q000097:blood; D001008:Anxiety Disorders / Q000097:blood* / Q000145:classification; D002395:Catecholamines / Q000097:blood; D013006:Growth Hormone / Q000097:blood; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D008734:Methoxyhydroxyphenylglycol / Q000097:blood; D009490:Neurosecretory Systems / Q000378:metabolism / Q000503:physiopathology*; D009771:Obsessive-Compulsive Disorder / Q000097:blood; D013315:Stress, Psychological / Q000097:blood
D002395:Catecholamines; D008734:Methoxyhydroxyphenylglycol; D000324:Adrenocorticotropic Hormone; D013006:Growth Hormone; D006854:Hydrocortisone